0001193125-17-217757.txt : 20170804 0001193125-17-217757.hdr.sgml : 20170804 20170629113155 ACCESSION NUMBER: 0001193125-17-217757 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20170629 FILER: COMPANY DATA: COMPANY CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001183765 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 943409596 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 BUSINESS PHONE: 512 896 1555 MAIL ADDRESS: STREET 1: 9301 AMBERGLEN BLVD STREET 2: SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78729 FORMER COMPANY: FORMER CONFORMED NAME: THRESHOLD PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020828 CORRESP 1 filename1.htm Acceleration request

THRESHOLD PHARMACEUTICALS, INC.

June 29, 2017

VIA EDGAR AND FEDEX

Division of Corporation Finance

United States Securities and Exchange Commission

100 F Street, N.E.

Mail Stop 4546

Washington, D.C. 20549

 

Attention: Chris Edwards
     Joseph McCann

 

Re: Acceleration Request of Threshold Pharmaceuticals, Inc.
     Registration Statement on Form S-4 (File No. 333-217993)

Dear Mr. Edwards:

Threshold Pharmaceuticals, Inc. (the “Registrant”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to cause the above-referenced Registration Statement on Form S-4, as amended, to become effective on Friday, June 30, 2017, at 4:00 p.m., Eastern Time, or as soon thereafter as practicable.

Thank you for your assistance. If you should have any questions, please contact Robert W. Phillips of Cooley LLP, counsel to the Registrant, at (415) 693-2020.

 

Very truly yours,

 

Threshold Pharmaceuticals, Inc.

/s/ Joel A. Fernandes

Joel A. Fernandes

Senior Vice President, Finance and Controller